Abacus Life, Inc. (NASDAQ:ABL) Receives Average Rating of “Moderate Buy” from Brokerages

Abacus Life, Inc. (NASDAQ:ABLGet Free Report) has received an average recommendation of “Moderate Buy” from the six research firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, four have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $13.1250.

Several research firms have commented on ABL. Wall Street Zen upgraded shares of Abacus Life from a “hold” rating to a “buy” rating in a research report on Saturday, August 9th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Abacus Life in a report on Wednesday. Finally, Piper Sandler reduced their price objective on Abacus Life from $12.00 to $10.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 2nd.

View Our Latest Stock Report on ABL

Institutional Trading of Abacus Life

Institutional investors have recently bought and sold shares of the stock. AlphaQuest LLC purchased a new position in Abacus Life during the second quarter worth $25,000. Darwin Wealth Management LLC bought a new stake in shares of Abacus Life in the 2nd quarter worth about $27,000. Raymond James Financial Inc. bought a new stake in shares of Abacus Life in the 2nd quarter worth about $34,000. Legal & General Group Plc purchased a new position in shares of Abacus Life during the 2nd quarter worth about $34,000. Finally, KLP Kapitalforvaltning AS bought a new position in Abacus Life during the 2nd quarter valued at about $41,000.

Abacus Life Stock Performance

NASDAQ:ABL opened at $5.96 on Thursday. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.76 and a quick ratio of 0.76. Abacus Life has a 1 year low of $4.60 and a 1 year high of $10.30. The stock’s 50 day simple moving average is $6.26 and its two-hundred day simple moving average is $6.66. The company has a market cap of $576.69 million, a price-to-earnings ratio of -99.33 and a beta of -0.01.

Abacus Life (NASDAQ:ABLGet Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.06. Abacus Life had a positive return on equity of 17.65% and a negative net margin of 0.72%.The firm had revenue of $56.23 million during the quarter, compared to the consensus estimate of $43.38 million. As a group, equities analysts anticipate that Abacus Life will post 0.62 earnings per share for the current fiscal year.

About Abacus Life

(Get Free Report)

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.

Further Reading

Analyst Recommendations for Abacus Life (NASDAQ:ABL)

Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.